{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:22:56Z","timestamp":1787505776358,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.schres.2022.03.006","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T18:47:27Z","timestamp":1648493247000},"page":"163-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Anti-aggressive effects of clozapine in involuntarily committed black patients with severe mental illness"],"prefix":"10.1016","volume":"243","author":[{"given":"Vincent S.","family":"Cavaliere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Glassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany A.","family":"DiPaula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Mackowick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi J.","family":"Wehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeboon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna L.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2022.03.006_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-244X-10-11","article-title":"Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia","volume":"10","author":"Ascher-Svanum","year":"2010","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2022.03.006_bb0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/070674371005500108","article-title":"Does clozapine promote employability and reduce offending among mentally disordered offenders?","volume":"55","author":"Balbuena","year":"2010","journal-title":"Can. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.schres.2022.03.006_bb0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S1742646407000313","article-title":"The effect of clozapine on adverse incidents in a low-secure challenging behaviour unit","volume":"2","author":"Beer","year":"2006","journal-title":"J. Psychiatr. Intensive Care"},{"issue":"2","key":"10.1016\/j.schres.2022.03.006_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/104012371402600207","article-title":"Clozapine in borderline personality disorder: a review of the evidence","volume":"26","author":"Beri","year":"2014","journal-title":"Ann. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2022.03.006_bb0025","first-page":"303","article-title":"Clozapine treatment and offending: a within-subject study of patients with psychotic disorders in Sweden","volume":"46","author":"Bhavsar","year":"2020","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.schres.2022.03.006_bb0030","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1176\/appi.ps.52.10.1358","article-title":"Risks for individuals with schizophrenia who are living in the community","volume":"52","author":"Brekke","year":"2001","journal-title":"Psychiatr. Serv."},{"issue":"4","key":"10.1016\/j.schres.2022.03.006_bb0035","first-page":"607","article-title":"Violence and schizophrenia: clozapine as a specific antiaggressive agent","volume":"23","author":"Buckley","year":"1995","journal-title":"Bull. Am. Acad. Psychiatry Law"},{"issue":"1","key":"10.1016\/j.schres.2022.03.006_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(00)00175-4","article-title":"Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital","volume":"53","author":"Chengappa","year":"2002","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2022.03.006_bb0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1176\/ps.45.3.269","article-title":"Effects of clozapine on use of seclusion and restraint at a state hospital","volume":"45","author":"Chiles","year":"1994","journal-title":"Psychiatr. Serv."},{"issue":"2","key":"10.1016\/j.schres.2022.03.006_bb0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/cbm.304","article-title":"Clozapine treatment of long-standing schizophrenia and serious violence: a two-year follow-up study of the first 50 patients treated with clozapine in Rampton high security hospital","volume":"9","author":"Dalal","year":"1999","journal-title":"Crim. Behav. Ment. Health"},{"issue":"1","key":"10.1016\/j.schres.2022.03.006_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/13651509909024759","article-title":"The effect of clozapine on aggressive behaviour in patients with chronic schizophrenia","volume":"3","author":"De Domenico","year":"1999","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"2","key":"10.1016\/j.schres.2022.03.006_bb0060","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/oxfordjournals.schbul.a033464","article-title":"The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia","volume":"26","author":"Drake","year":"2000","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2022.03.006_bb0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1176\/ps.45.3.271","article-title":"Patient response to clozapine in a forensic psychiatric hospital","volume":"45","author":"Ebrahim","year":"1994","journal-title":"Psychiatr. Serv."},{"issue":"12","key":"10.1016\/j.schres.2022.03.006_bb0070","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1038\/s41386-018-0161-2","article-title":"Efficacy of typical and atypical antipsychotic medication on hostility in patients with psychosis-spectrum disorders: a review and meta-analysis","volume":"43","author":"Faay","year":"2018","journal-title":"Neuropsychopharmacology: official publication of the american college ofNeuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.schres.2022.03.006_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000120","article-title":"Schizophrenia and violence: systematic review and meta-analysis","volume":"6","author":"Fazel","year":"2009","journal-title":"PLoS Med."},{"issue":"9","key":"10.1016\/j.schres.2022.03.006_bb0080","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1017\/S146114571100201X","article-title":"A systematic review of the evidence of clozapine's anti-aggressive effects","volume":"15","author":"Frogley","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2022.03.006_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2017.11.005","article-title":"Predicting time to recall in patients conditionally released from a secure forensic hospital: a survival analysis","volume":"49","author":"Jewell","year":"2018","journal-title":"Eur. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2022.03.006_bb0090","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1176\/appi.ajp.2020.177901","article-title":"The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia","volume":"177","author":"Keepers","year":"2020","journal-title":"Am. J. Psychiatr."},{"issue":"9","key":"10.1016\/j.schres.2022.03.006_bb0095","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.4088\/JCP.v67n0911","article-title":"Clozapine utilization and outcomes by race in a public mental health system: 1994\u20132000","volume":"67","author":"Kelly","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2022.03.006_bb0100","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/schbul\/sbl068","article-title":"Clozapine underutilization and discontinuation in African Americans due to leucopenia","volume":"33","author":"Kelly","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.03.006_bb9000","series-title":"Severe Neutropenia in African-Descent Patients Treated with Clozapine: Results of a Six-Month, Multinational Open-label Clinical Trial [Oral Session]. SIRS 2021 Virtual Conference","author":"Kelly","year":"2021"},{"issue":"6","key":"10.1016\/j.schres.2022.03.006_bb0105","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archpsyc.63.6.622","article-title":"Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Krakowski","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2022.03.006_bb0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.chi.0000145371.23122.5a","article-title":"Clozapine: its impact on aggressive behavior among children and adolescents with schizophrenia","volume":"44","author":"Kranzler","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2022.03.006_bb0115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/schbul\/sbp130","article-title":"The schizophrenia patient outcomes research team (PORT): updated treatment recommendations 2009","volume":"36","author":"Kreyenbuhl","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"11","key":"10.1016\/j.schres.2022.03.006_bb0120","first-page":"395","article-title":"Restraint, seclusion, and clozapine","volume":"53","author":"Mallya","year":"1992","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2022.03.006_bb0125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2022.03.006_bb0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1176\/ps.47.1.46","article-title":"Effectiveness of clozapine and a social learning program for severely disabled psychiatric inpatients","volume":"47","author":"Menditto","year":"1996","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2022.03.006_bb0135","series-title":"The Color of Justice: Racial and Ethnic Disparity in State Prisons","author":"Nellis","year":"2021"},{"key":"10.1016\/j.schres.2022.03.006_bb0140","series-title":"Prisoner Involvement in Research (2003)","author":"OHRP","year":"2003"},{"issue":"3","key":"10.1016\/j.schres.2022.03.006_bb0145","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"1","key":"10.1016\/j.schres.2022.03.006_bb0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11126-017-9521-z","article-title":"Clozapine in reducing aggression and violence in forensic populations","volume":"89","author":"Patchan","year":"2018","journal-title":"Psychiatry Q."},{"issue":"3","key":"10.1016\/j.schres.2022.03.006_bb0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0920-9964(96)00051-5","article-title":"Effect of clozapine on physical and verbal aggression","volume":"22","author":"Rabinowitz","year":"1996","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.schres.2022.03.006_bb0160","first-page":"219","article-title":"The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital","volume":"54","author":"Ratey","year":"1993","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.03.006_bb0165","article-title":"Pharmacological interventions to reduce violence in patients with schizophrenia in forensic psychiatry","volume":"1\u201311","author":"Reisegger","year":"2021","journal-title":"CNS Spectrums"},{"issue":"9","key":"10.1016\/j.schres.2022.03.006_bb0170","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0706743717720448","article-title":"Guidelines for the pharmacotherapy of schizophrenia in adults","volume":"62","author":"Remington","year":"2017","journal-title":"Can. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2022.03.006_bb0175","doi-asserted-by":"crossref","first-page":"e1454","DOI":"10.4088\/JCP.15m10315","article-title":"Evaluation of the safety of clozapine use in patients with benign neutropenia","volume":"77","author":"Richardson","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2022.03.006_bb0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/875512250201800403","article-title":"Impact of clozapine versus haloperidol on conditional release time and rates of revocation in a forensic psychiatric population","volume":"18","author":"Stoner","year":"2002","journal-title":"J. Pharm. Technol."},{"issue":"Suppl. 12","key":"10.1016\/j.schres.2022.03.006_bb0185","first-page":"43","article-title":"The effects of clozapine on aggression and substance abuse in schizophrenic patients","volume":"60","author":"Volavka","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2022.03.006_bb0190","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004714-199308000-00012","article-title":"Clozapine effects on hostility and aggression in schizophrenia","volume":"13","author":"Volavka","year":"1993","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2022.03.006_bb0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.jcp.0000117424.05703.29","article-title":"Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol","volume":"24","author":"Volavka","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2022.03.006_bb0200","series-title":"Handbook of Correctional Mental Health","first-page":"43","article-title":"Prevalence and assessment of mental disorders in correctional settings","author":"Weinstein","year":"2005"},{"issue":"7","key":"10.1016\/j.schres.2022.03.006_bb0205","first-page":"700","article-title":"Clinical review of clozapine treatment in a state hospital","volume":"43","author":"Wilson","year":"1992","journal-title":"Hosp. Community Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2022.03.006_bb0210","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1176\/ps.46.4.386","article-title":"18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital","volume":"46","author":"Wilson","year":"1995","journal-title":"Psychiatr. Serv."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422001347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422001347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:47:10Z","timestamp":1760298430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996422001347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":43,"alternative-id":["S0920996422001347"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2022.03.006","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-aggressive effects of clozapine in involuntarily committed black patients with severe mental illness","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2022.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}